01 4Zerbaxa
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 130
2019 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : -1
2020 Revenue in Millions : 130
Growth (%) : -101
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 169
2021 Revenue in Millions : -1
Growth (%) : Not Meaningful
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 218
2022 Revenue in Millions : 169
Growth (%) : 29
LOOKING FOR A SUPPLIER?